| NODIS Library | Human Resources and Personnel(3000s) | Search |

NASA Ball NASA
Procedural
Requirements
NPR 3792.1D
Effective Date: May 14, 2018
Expiration Date: May 14, 2023
COMPLIANCE IS MANDATORY FOR NASA EMPLOYEES
Printable Format (PDF)

Subject: NASA’s Plan for a Drug Free Workplace (Updated w/Change 2)

Responsible Office: Office of the Chief Human Capital Officer


| TOC | ChangeHistory | Preface | Chapter1 | Chapter2 | Chapter3 | Chapter4 | Chapter5 | Chapter6 | Chapter7 | AppendixA | AppendixB | AppendixC | ALL |

Appendix A. Definitions

Adulterated Specimen. A urine specimen containing either a substance that is not a normal constituent or containing an endogenous substance at a concentration that is not a normal physiological concentration.

Applicant. Any individual tentatively selected for a TDP as a result of applying for the position through a vacancy announcement, who has not, immediately prior to the selection, been subject to random testing by NASA. This includes current NASA employees who are being reassigned from a non-TPD to a TPD.

Collection Site. A place designated by the Agency where individuals present themselves for the purpose of providing a specimen of their urine to be analyzed for the presence of drugs.

Collector. A person who has successfully completed training to instruct and assist individuals at a collection site and who receives and makes an initial examination of the urine specimen provided by those individuals.

Days. Calendar days unless specified otherwise.

Dilute Specimen. A urine specimen with less than expected physiological constituents but within the physiologically producible ranges of human urine and may be reported in conjunction with a positive or negative drug test.

Disciplinary Agreement. An agreement between the Agency and an employee that contains terms under which discipline will be mitigated or held in abeyance.

Follow-up Test. A specimen collected from an employee to ensure that the employee remains drug-free after being reinstated to a TDP.

Illegal Drug. A controlled substance included in Schedule I or II, as defined by

21 U.S.C. § 802(6), the possession of which is unlawful under Chapter 13 of that Title. The term illegal drug does not mean the use of a controlled substance pursuant to a valid prescription or other uses authorized by law, not otherwise in conflict with Federal law.

Invalid Result. A result reported by an HHS certified laboratory to a Medical Review Officer, in accordance with established drug testing criteria for a urine specimen that contains an unidentified adulterant, contains an unidentified interfering substance, has an abnormal physical characteristic, or has an endogenous substance at an abnormal concentration that prevents the laboratory from completing testing or obtaining a valid drug test result.

Last Chance Agreement. An agreement between the Agency and an employee that contains terms under which the employee will be given a last opportunity to maintain employment.

Management Official. An employee required or authorized to formulate, determine, or influence Agency policies.

Negative/Dilute Result. A result reported by an HHS-certified laboratory to a Medical Review Officer when a result cannot be determined based on specific constituents but is within the physiologically producible ranges of human specimen.

Negative Result. A result reported by an HHS-certified laboratory when a specimen contains no drug or a drug metabolite that is less than the cutoff concentration for that drug and the specimen is a valid specimen.

Positive Result. A result reported by an HHS-certified laboratory when a specimen contains a drug or drug metabolite.

Responsible Official. An individual whose assigned job duties include authority over the location of the accident.

Sensitivity-Level Designations. All positions are evaluated for a position sensitivity designation commensurate with the responsibilities and assignments of the position as they relate to the impact on the national security, including but not limited to eligibility for access to classified information. Sensitivity-level designations and investigative requirements are determined in accordance with 5 U.S.C. 1400, subpt. B.

Specimen. Urine and/or an alternative (e.g., oral fluid) collected from an individual that may be subdivided for the purposes of drug testing.

Split Specimen. A urine specimen that has been subdivided into two parts (Bottle A and Bottle B) and independently sealed in the presence of the individual being tested.

Substituted Specimen. A urine specimen that could not have been derived from the individual's body at the time of collection because it is inconsistent with normal physiology.

Supervisor. An employee having authority to hire, direct, assign, promote, reward, transfer, furlough, layoff, recall, suspend, discipline, or remove employees, to adjust their grievances, or to effectively recommend such action, if the exercise of the authority is not merely routine or clerical in nature but requires the consistent exercise of independent judgment.

Testing Designated Positions. In accordance with the guidelines identified in Appendix C, positions that have been designated by management for random testing.

Voluntary Test. A specimen collected from an employee who is not in a TDP and who has volunteered for random testing.



| TOC | ChangeHistory | Preface | Chapter1 | Chapter2 | Chapter3 | Chapter4 | Chapter5 | Chapter6 | Chapter7 | AppendixA | AppendixB | AppendixC | ALL |
 
| NODIS Library | Human Resources and Personnel(3000s) | Search |

DISTRIBUTION:
NODIS


This document does not bind the public, except as authorized by law or as incorporated into a contract. This document is uncontrolled when printed. Check the NASA Online Directives Information System (NODIS) Library to verify that this is the correct version before use: https://nodis3.gsfc.nasa.gov.